treprostinil 0.08 MG Inhalation Powder

RxNorm concept 2697737, clinical drug (scd). Prescribable name: treprostinil 80 MCG Inhalation Powder.

RxCUI: 2697737
Term type: Clinical drug (SCD)
Status: Active

Request

curl https://api.healthcare.dev/v1/drugs/rxnorm/2697737 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Concept

Ingredients and related concepts

Ingredients

treprostinil 343048

Other names

treprostinil 80 MCG Inhalation Powder

Related concepts

treprostinil 0.08 MG (SCDC, consists of)
{112 (treprostinil 0.048 MG Inhalation Powder) / 112 (treprostinil 0.08 MG Inhalation Powder) } Pack (GPCK, contained in)
{112 (treprostinil 0.064 MG Inhalation Powder) / 112 (treprostinil 0.08 MG Inhalation Powder) } Pack (GPCK, contained in)
Inhalation Powder (DF, has dose form)
treprostinil 0.08 MG Inhalation Powder [Tyvaso] (SBD, has tradename)

Linked data

NDCs

RxNorm links no NDCs to this concept.

Use it

Look up 2697737 from code or an agent

curl

curl https://api.healthcare.dev/v1/drugs/rxnorm/2697737 \
  -H "Authorization: Bearer $HDEV_API_KEY"

MCP prompt

Using the healthcare.dev MCP server, look up RxNorm concept 2697737. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.

Get a free key RxNorm docs Connect the MCP server

Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.